Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026;3(1):5.
doi: 10.1038/s44355-026-00054-2. Epub 2026 Feb 2.

Optimising the induction of inflammation within preterm infant-derived intestinal epithelial organoids

Affiliations

Optimising the induction of inflammation within preterm infant-derived intestinal epithelial organoids

Jonathan A Chapman et al. NPJ Gut Liver. 2026.

Abstract

Preterm infants born <32 weeks gestation have abnormal microbial colonisation and dysregulated inflammation within the gut. Preterm infant-derived intestinal organoids (PIOs) represent a valuable model for investigating gut microbiome-host interactions and inflammatory responses. We optimised an inflammation model in PIO monolayers incubated within an anaerobic co-culture system that recreates the physiological oxygen gradient of the intestinal epithelium. We trialled multiple stimuli, including live and heat-killed pathobiont consortia, lipopolysaccharide (LPS) and flagellin. We found that a combination of apical LPS and basolateral flagellin, incubated for 3 h, elicited the most robust response. This was characterised by enhanced pro-inflammatory cytokine secretion, the potential for chemokine-driven immune recruitment, TNFα and IL17C pathway signalling, shifts from NF-κB to AP-1-mediated responses, and signs of tissue remodelling. This provides a framework for appropriate study design to disentangle the impacts of microbiome-host interactions in health and disease using intestinal organoids.

Keywords: Gastrointestinal diseases; Gastrointestinal system; Inflammation; Intestinal stem cells.

PubMed Disclaimer

Conflict of interest statement

Competing interestsN.D.E. and J.E.B. declare research funding paid to their institution from Prolacta Biosciences, NeoKare UK and Danone Early Life Nutrition for grants between 2016-2022. N.D.E. declares lecture honoraria from Nestle Nutrition Institute and Abbot nutrition and declares providing consultancy advice to legal firms involved in class action for infants developing NEC; all honoraria and consultancy fees were donated to charity. C.J.S. declares lecture honoraria from Nestlé Nutrition Institute. The remaining authors declare no conflicts.

Figures

Fig. 1
Fig. 1. Comparisons of the effects of incubating preterm infant-derived intestinal epithelial organoids (PIOs) with purified bacterial stimuli (flagellin (100 μg/ml) and/or lipopolysaccharide (LPS) (100 μg/ml)), a cocktail of live bacterial pathobionts, or heat-killed bacterial pathobionts, for either 24 h or 3 h.
A Schematic of PIO inflammation assays. B Bar plots showing the changes in both apical and basolateral IL8 secretion from PIOs, for both the 24 h and 3 h incubations. Within each plot, conditions with the same letters are not significantly different. C Principal component analysis of PIO proteomics data for both the 24 h and 3 h incubations. Groups are coloured by condition. D Per condition comparison of the number of differentially abundant proteins identified within PIO proteomics data for both incubation durations. Thresholds for differential abundance were set at adjusted p ≤ 0.05 and log2(foldchange) ≥ +/− 0.58 (real term fold change of +/−1.5).
Fig. 2
Fig. 2. Comparisons of the effects of incubating preterm infant-derived intestinal epithelial organoids (PIOs) with either flagellin (100 ng/ml) or lipopolysaccharide (LPS) (100 ng/ml), added either apically or basolaterally, for 6 h, and a 3 h incubation with basolateral flagellin and apical LPS (both 100 ng/ml).
A Schematic of PIO 6 h inflammation assay. B Bar plots showing the changes in both apical and basolateral IL8 secretion from PIOs, following 6 h incubation. Within each plot, conditions with the same letters are not significantly different. C Schematic of PIO 3 h inflammation assay. D Bar plots showing the changes in both apical and basolateral IL8 secretion from PIOs, following 3 h incubation. E Volcano plot showing changes in the proteomes of PIOs following 3 h incubation with apical LPS and basolateral flagellin versus untreated PIOs. The thresholds used for differential abundance are marked with dashed lines (adjusted p ≤ 0.05 and log2(foldchange) ≥ +/− 0.58). Differentially abundant proteins of interest are labelled on the plot, with blue signifying downregulation, and red upregulation. F Heatmap showing abundances of proteins from the 3 h incubation experiment, excluded from Limma fold change analysis due to being undetected in one or other condition. G KEGG pathways that were significantly enriched within PIO proteins upregulated during treatment with inflammatory stimuli for 3 h. H Reactome pathways that were significantly enriched within PIO proteins downregulated during treatment with inflammatory stimuli for 3 h.

References

    1. Clevers, H. Modeling development and disease with organoids. Cell165, 1586–1597 (2016). - DOI - PubMed
    1. Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet.19, 671–687 (2018). - DOI - PubMed
    1. Wang, Y. & Qin, J. Advances in human organoids-on-chips in biomedical research. Life Med.2, lnad007 (2023). - DOI - PMC - PubMed
    1. Cala, G., Sina, B., De Coppi, P., Giobbe, G. G. & Gerli, M. F. M. Primary human organoids models: Current progress and key milestones. Front. Bioeng. Biotechnol.11, 1058970 (2023). - DOI - PMC - PubMed
    1. VanDussen, K. L. et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut64, 911–920 (2015). - DOI - PMC - PubMed

LinkOut - more resources